Range
1.08 - 1.17
Vol / Avg.
12.1M/12.9M
Div / Yield
-
52 Wk
0.45 - 3
Mkt Cap
202.4M
Payout Ratio
-
Open
1.16
P/E
-
EPS
-0.28
Shares
179.1M
Outstanding
179.1M
Total Float
170.3M
Benzinga - Jul 6, 2021, 4:57AM
Benzinga - Jul 2, 2021, 4:43PM
Benzinga - Jul 2, 2021, 7:33AM
Benzinga - Jul 2, 2021, 7:15AM
Benzinga - Jul 2, 2021, 7:12AM
Benzinga - Jun 24, 2021, 12:13PM
Benzinga - May 28, 2021, 12:24PM
Benzinga - May 28, 2021, 8:06AM
Benzinga - May 28, 2021, 7:04AM
Benzinga - May 27, 2021, 5:03PM
Benzinga - May 14, 2021, 7:36AM
Benzinga - May 14, 2021, 7:03AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.070-0.050 0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ITRMIterum Therapeutics-2.59%202.4M

Iterum Therapeutics Frequently Asked Questions

Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) competitors?

A

Other companies in Iterum Therapeutics’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Satsuma Pharmaceuticals (NASDAQ:STSA), Jaguar Health (NASDAQ:JAGX), Tricida (NASDAQ:TCDA) and Kaleido Biosciences (NASDAQ:KLDO).

Q

What is the target price for Iterum Therapeutics (ITRM) stock?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on May 28, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.13 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A
Iterum Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.